Key Development Central Pharmaceutical Joint Stock Company VIDIPHA (HoSE: VDP) has recorded a major restructuring of its shareholder register, coinciding... Read more
Category: Uncategorized
Medical Licensing Reform: Vietnam Ministry of Health & National Medical Council Accelerate Preparations for Historic 2027 Inaugural Physician Licensure Examination
Key Development On the afternoon of August 26, 2026, Permanent Vice Minister of Health Vu Manh Ha, MD, PhD and... Read more
Clinical Laboratory Quality Accreditation: Nghe An Oncology Hospital Secures International ISO 15189:2022 Certification – Becoming the First Public Hospital in the Province to Achieve Global Laboratory Standards
Key Development On August 26, 2026, Nghe An Oncology Hospital announced that its Department of Laboratory Medicine has officially been... Read more
Public Health Enforcement & Illicit Trade Control: Hanoi Mobilizes Citizen Whistleblowing Campaign and Digital Surveillance to Crack Down on E-Cigarette and Heated Tobacco Distribution Networks
Key Development The Hanoi People's Committee has issued an urgent directive mandating an intensified municipal enforcement campaign targeting the smuggling,... Read more
Health Insurance Medical Device Formulary: Vietnam MOH Refines Draft Circular Prioritizing Feasibility, Transparency, and Digital Interoperability
Key Development On the afternoon of August 25, 2026, Permanent Vice Minister of Health Vu Manh Ha, MD, PhD chaired... Read more
Quality Control & Regulatory Enforcement: Drug Administration of Vietnam Fines Pharmedic VND 50 Million for Class 3 Quality Defect in Sodium Chloride 0.9% Eye Drops Failing Clarity Standards
Key Development The Drug Administration of Vietnam (DAV) under the Ministry of Health has officially issued an administrative sanction decision... Read more
FDA EXPANDS IMAAVY: J&J TURNS FCRN BLOCKADE INTO A RARE AUTOIMMUNE GROWTH PLATFORM
Key Development On August 24, 2026, the U.S. FDA expanded the approval of Johnson & Johnson’s IMAAVY® (nipocalimab-aahu) to treat... Read more
ROCHE–ELI LILLY BRINGS ALZHEIMER’S BLOOD TESTING INTO MAINSTREAM DIAGNOSTIC INFRASTRUCTURE: COMPETITION IS SHIFTING FROM DRUGS TO ECOSYSTEMS
Key Development The FDA has cleared Elecsys pTau217, a blood-based biomarker test developed by Roche in collaboration with Eli Lilly,... Read more
Non-Incretin Cardiometabolic Licensing: Genentech Pays $190 Million Upfront in $2.3 Billion Global License Agreement with Hanmi Pharm for Muscle-Preserving Obesity Peptide HM17321
Key Development Biotechnology pioneer Genentech (a member of the Roche Group) has entered into an exclusive worldwide collaboration and license... Read more









